Your account is not claimed yet. You can sign up with ORCID to claim your account.

James L Rubenstein

Years Active: 2019-2023
Publications (10 Years): 5

UCSF Helen Diller Family Comprehensive Cancer Center

Stanford University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UCSF Helen Diller Family Comprehensive Cancer Center Jul 1o 1995

United States

Professor :: Medicine

Education History

Stanford University Sep 20o 1980 - Jun 10o 1985

United States

BSC :: Biological Sciences

Publications

Andreas M Rauschecker, Shirley S Mo, Michael Randall, John Shen-Sampas, James L Rubenstein
Tafasitamab at the blood-brain barrier. British journal of haematology (2023)
James L Rubenstein
Primary CNS Lymphoma: Progress With Dose-Intensive Consolidation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (32) (2022)
Emily Kang, Cigall Kadoch, James L Rubenstein, Lewis L Lanier, James A Wells
A functional mammalian display screen identifies rare antibodies that stimulate NK cell-mediated cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America 118 (31) (2021)
Mazie Tsang, Joseph Cleveland, James L Rubenstein
On point in primary CNS lymphoma. Hematological oncology 38 (5) (2020)
Khoan Vu, Gabriel Mannis, Jimmy Hwang, Huimin Geng, James L Rubenstein
Low-dose lenalidomide maintenance after induction therapy in older patients with primary central nervous system lymphoma. British journal of haematology 186 (1) (2019)

James L Rubenstein.css-eqlu8i{font-size:small;padding-left:4px;}